ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS DOES NOT ATTENUATE CUTANEOUS TUMOUR NECROSIS FACTOR ACTIVITY FOLLOWING A TUBERCULIN SKIN TEST

被引：0
|
作者：
Byng-Maddick, Rachel [1 ]
Haas, Carolin [1 ]
Ehrenstein, Michael [2 ]
Noursadeghi, Mahdad [1 ]
机构：
[1] UCL, Infect & Immun, London, England
[2] UCL, Med, London, England
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
208
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [21] Does sex or ethnicity impact anti-tumour necrosis factor agent use in rheumatoid arthritis?
    Dennison, Elaine M.
    Jameson, Karen A.
    Marks, Jonathan
    Watson, Kath
    Hyrich, Kimme
    Symmons, Deborah
    Cooper, Cyrus
    [J]. RHEUMATOLOGY, 2017, 56 (04) : 663 - 665
  • [22] The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-α therapy
    Bingham, SJ
    Buch, MH
    Tennant, A
    Emery, P
    [J]. RHEUMATOLOGY, 2004, 43 (03): : 364 - 368
  • [23] Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis
    Hishitani, Y.
    Ogata, A.
    Shima, Y.
    Hirano, T.
    Ebina, K.
    Kunugiza, Y.
    Shi, K.
    Narazaki, M.
    Hagihara, K.
    Tomita, T.
    Yoshikawa, H.
    Tanaka, T.
    Kumanogoh, A.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (04) : 253 - 259
  • [24] Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis
    Rajakulendran, S.
    Gadsby, K.
    Allen, D.
    O'Reilly, S.
    Deighton, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) : 1678 - 1679
  • [25] Peptostreptococcal pericarditis complicating anti-tumour necrosis factor α treatment in rheumatoid arthritis
    Harney, S
    O'Shea, FD
    FitzGerald, O
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (07) : 653 - 654
  • [26] Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
    AI Catrina
    S Ernestam
    E af Klint
    L Klareskog
    AK Ulfgren
    [J]. Arthritis Res Ther, 6
  • [27] Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
    Catrina, AI
    Ernestam, S
    Klint, EA
    Klareskog, L
    Ulfgren, AK
    [J]. ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 1) : S9 - S9
  • [28] Sleep Evaluation Before and After Initiation of Anti-Tumour Necrosis Factor Therapy in Rheumatoid Arthritis
    Taylor-Gjevre, Regina
    Gjevre, John
    Nair, Bindu
    Skomro, Robert
    Lim, Hyun
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1151 - 1151
  • [29] ANTI-TNF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS DOES NOT ATTENUATE CUTANEOUS TNF ACTIVITY FOLLOWING A TUBERCULIN SKIN TEST
    Byng-Maddick, R.
    Haas, C.
    Ehrenstein, M.
    Noursadeghi, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 487 - 487
  • [30] ANTI TUMOUR NECROSIS FACTOR THERAPY IN RHEUMATOID ARTHRITIS: THE RISK OF TUBERCULOSIS
    Langtree, Matthew
    Lam, Manda
    Malipeddi, Aruna
    Hassan, Waji
    [J]. RHEUMATOLOGY, 2010, 49 : I92 - I92
12345